Inhibition of pluripotency networks by the Rb tumor suppressor restricts reprogramming and tumorigenesis

Cell Stem Cell

Volumn 16, Issue 1, 2015, Pages 39-50

  Kareta, Michael S ^a,b   Gorges, Laura L ^a   Hafeez, Sana ^b   Benayoun, Bérénice A ^a   Marro, Samuele ^b   Zmoos, Anne Flore ^a   Cecchini, Matthew J ^c   Spacek, Damek ^a   Batista, Luis F Z ^a,b   O'Brien, Megan ^a   Ng, Yi Han ^b   Ang, Cheen Euong ^b   Vaka, Dedeepya ^a   Artandi, Steven E ^a,b   Dick, Frederick A ^c   Brunet, Anne ^a   Sage, Julien ^a   Wernig, Marius ^b  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR SOX2; CHROMATIN; HOMEODOMAIN PROTEIN; NANOG PROTEIN, MOUSE; PROTEIN BINDING; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR SOX;

ARTICLE; CARCINOGENESIS; CELL CYCLE; CELL DIFFERENTIATION; CELL FATE; CHROMATIN; CONTROLLED STUDY; NUCLEAR REPROGRAMMING; PLIABILITY; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; REGULATORY MECHANISM; TUMOR SUPPRESSOR GENE; ANIMAL; CYTOLOGY; DEFICIENCY; FIBROBLAST; GENETICS; HUMAN; INDUCED PLURIPOTENT STEM CELL; METABOLISM; MOUSE; PATHOLOGY;

MUS;

ANIMALS; CARCINOGENESIS; CELL CYCLE; CELLULAR REPROGRAMMING; CHROMATIN; FIBROBLASTS; HOMEODOMAIN PROTEINS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE; OCTAMER TRANSCRIPTION FACTOR-3; PROTEIN BINDING; REPRESSOR PROTEINS; RETINOBLASTOMA PROTEIN; SOXB1 TRANSCRIPTION FACTORS;

EID: 84920747084     PISSN: 19345909     EISSN: 18759777     Source Type: Journal    
DOI: 10.1016/j.stem.2014.10.019     Document Type: Article

References (50)

1. M.G. Andrusiak, R. Vandenbosch, F.A. Dick, D.S. Park, and R.S. Slack LXCXE-independent chromatin remodeling by Rb/E2f mediates neuronal quiescence Cell Cycle 12 2013 1416 1423
2. A. Banito, S.T. Rashid, J.C. Acosta, S. Li, C.F. Pereira, I. Geti, S. Pinho, J.C. Silva, V. Azuara, and M. Walsh Senescence impairs successful reprogramming to pluripotent stem cells Genes Dev. 23 2009 2134 2139
3. L.F. Batista, M.F. Pech, F.L. Zhong, H.N. Nguyen, K.T. Xie, A.J. Zaug, S.M. Crary, J. Choi, V. Sebastiano, and A. Cherry Telomere shortening and loss of self-renewal in dyskeratosis congenita induced pluripotent stem cells Nature 474 2011 399 402
4. B.A. Benayoun, E.A. Pollina, D. Ucar, S. Mahmoudi, K. Karra, E.D. Wong, K. Devarajan, A.C. Daugherty, A.B. Kundaje, and E. Mancini H3K4me3 breadth is linked to cell identity and transcriptional consistency Cell 158 2014 673 688
5. R.J. Bourgo, C. Thangavel, A. Ertel, J. Bergseid, A.K. McClendon, L. Wilkens, A.K. Witkiewicz, J.Y. Wang, and E.S. Knudsen RB restricts DNA damage-initiated tumorigenesis through an LXCXE-dependent mechanism of transcriptional control Mol. Cell 43 2011 663 672
6. T. Brambrink, R. Foreman, G.G. Welstead, C.J. Lengner, M. Wernig, H. Suh, and R. Jaenisch Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells Cell Stem Cell 2 2008 151 159
7. D.L. Burkhart, and J. Sage Cellular mechanisms of tumour suppression by the retinoblastoma gene Nat. Rev. Cancer 8 2008 671 682
8. D.L. Burkhart, L.K. Ngai, C.M. Roake, P. Viatour, C. Thangavel, V.M. Ho, E.S. Knudsen, and J. Sage Regulation of RB transcription in vivo by RB family members Mol. Cell. Biol. 30 2010 1729 1745
9. D.L. Burkhart, S.E. Wirt, A.F. Zmoos, M.S. Kareta, and J. Sage Tandem E2F binding sites in the promoter of the p107 cell cycle regulator control p107 expression and its cellular functions PLoS Genet. 6 2010 e1001003
10. E. Calo, J.A. Quintero-Estades, P.S. Danielian, S. Nedelcu, S.D. Berman, and J.A. Lees Rb regulates fate choice and lineage commitment in vivo Nature 466 2010 1110 1114
11. B.W. Carey, S. Markoulaki, J.H. Hanna, D.A. Faddah, Y. Buganim, J. Kim, K. Ganz, E.J. Steine, J.P. Cassady, and M.P. Creyghton Reprogramming factor stoichiometry influences the epigenetic state and biological properties of induced pluripotent stem cells Cell Stem Cell 9 2011 588 598
12. M.J. Cecchini, and F.A. Dick The biochemical basis of CDK phosphorylation-independent regulation of E2F1 by the retinoblastoma protein Biochem. J. 434 2011 297 308
13. M.J. Cecchini, M.J. Thwaites, S. Talluri, J.I. MacDonald, D.T. Passos, J.L. Chong, P. Cantalupo, P.M. Stafford, M.T. Saenz-Robles, and S.M. Francis A retinoblastoma allele that is mutated at its common E2F interaction site inhibits cell proliferation in gene-targeted mice Mol. Cell Biol. 34 2014 2029 2045
14. A.W. Cheng, H. Wang, H. Yang, L. Shi, Y. Katz, T.W. Theunissen, S. Rangarajan, C.S. Shivalila, D.B. Dadon, and R. Jaenisch Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system Cell Res. 23 2013 1163 1171
15. A. Chicas, X. Wang, C. Zhang, M. McCurrach, Z. Zhao, O. Mert, R.A. Dickins, M. Narita, M. Zhang, and S.W. Lowe Dissecting the unique role of the retinoblastoma tumor suppressor during cellular senescence Cancer Cell 17 2010 376 387
16. M. Chinnam, and D.W. Goodrich RB1, development, and cancer Curr. Top. Dev. Biol. 94 2011 129 169
17. J.F. Conklin, and J. Sage Keeping an eye on retinoblastoma control of human embryonic stem cells J. Cell. Biochem. 108 2009 1023 1030
18. J.H. Dannenberg, A. van Rossum, L. Schuijff, and H. te Riele Ablation of the retinoblastoma gene family deregulates G(1) control causing immortalization and increased cell turnover under growth-restricting conditions Genes Dev. 14 2000 3051 3064
19. J.R. Dixon, S. Selvaraj, F. Yue, A. Kim, Y. Li, Y. Shen, M. Hu, J.S. Liu, and B. Ren Topological domains in mammalian genomes identified by analysis of chromatin interactions Nature 485 2012 376 380
20. C.R. Goding, D. Pei, and X. Lu Cancer: pathological nuclear reprogramming? Nat. Rev. Cancer 14 2014 568 573
21. J. Hanna, K. Saha, B. Pando, J. van Zon, C.J. Lengner, M.P. Creyghton, A. van Oudenaarden, and R. Jaenisch Direct cell reprogramming is a stochastic process amenable to acceleration Nature 462 2009 595 601
22. K. Hochedlinger, Y. Yamada, C. Beard, and R. Jaenisch Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues Cell 121 2005 465 477
23. C.E. Isaac, S.M. Francis, A.L. Martens, L.M. Julian, L.A. Seifried, N. Erdmann, U.K. Binné, L. Harrington, P. Sicinski, and N.G. Bérubé The retinoblastoma protein regulates pericentric heterochromatin Mol. Cell. Biol. 26 2006 3659 3671
24. T. Jacks, A. Fazeli, E.M. Schmitt, R.T. Bronson, M.A. Goodell, and R.A. Weinberg Effects of an Rb mutation in the mouse Nature 359 1992 295 300
25. L.M. Julian, R. Vandenbosch, C.A. Pakenham, M.G. Andrusiak, A.P. Nguyen, K.A. McClellan, D.S. Svoboda, D.C. Lagace, D.S. Park, and G. Leone Opposing regulation of Sox2 by cell-cycle effectors E2f3a and E2f3b in neural stem cells Cell Stem Cell 12 2013 440 452
26. R.P. Koche, Z.D. Smith, M. Adli, H. Gu, M. Ku, A. Gnirke, B.E. Bernstein, and A. Meissner Reprogramming factor expression initiates widespread targeted chromatin remodeling Cell Stem Cell 8 2011 96 105
27. V. Krizhanovsky, and S.W. Lowe Stem cells: The promises and perils of p53 Nature 460 2009 1085 1086
28. F. Li, Z. He, J. Shen, Q. Huang, W. Li, X. Liu, Y. He, F. Wolf, and C.Y. Li Apoptotic caspases regulate induction of iPSCs from human fibroblasts Cell Stem Cell 7 2010 508 520
29. H. Li, M. Collado, A. Villasante, A. Matheu, C.J. Lynch, M. Cañamero, K. Rizzoti, C. Carneiro, G. Martínez, and A. Vidal p27(Kip1) directly represses Sox2 during embryonic stem cell differentiation Cell Stem Cell 11 2012 845 852
30. Y. Liu, B. Clem, E.K. Zuba-Surma, S. El-Naggar, S. Telang, A.B. Jenson, Y. Wang, H. Shao, M.Z. Ratajczak, J. Chesney, and D.C. Dean Mouse fibroblasts lacking RB1 function form spheres and undergo reprogramming to a cancer stem cell phenotype Cell Stem Cell 4 2009 336 347
31. M.S. Longworth, and N.J. Dyson pRb, a local chromatin organizer with global possibilities Chromosoma 119 2010 1 11
32. Y. Lu, C. Futtner, J.R. Rock, X. Xu, W. Whitworth, B.L. Hogan, and M.W. Onaitis Evidence that SOX2 overexpression is oncogenic in the lung PLoS ONE 5 2010 e11022
33. A.L. Manning, and N.J. Dyson RB: mitotic implications of a tumour suppressor Nat. Rev. Cancer 12 2012 220 226
34. M.A. Marqués-Torrejón, E. Porlan, A. Banito, E. Gómez-Ibarlucea, A.J. Lopez-Contreras, O. Fernández-Capetillo, A. Vidal, J. Gil, J. Torres, and I. Fariñas Cyclin-dependent kinase inhibitor p21 controls adult neural stem cell expansion by regulating Sox2 gene expression Cell Stem Cell 12 2013 88 100
35. J. McEvoy, J. Flores-Otero, J. Zhang, K. Nemeth, R. Brennan, C. Bradley, F. Krafcik, C. Rodriguez-Galindo, M. Wilson, and S. Xiong Coexpression of normally incompatible developmental pathways in retinoblastoma genesis Cancer Cell 20 2011 260 275
36. A. Meissner, M. Wernig, and R. Jaenisch Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells Nat. Biotechnol. 25 2007 1177 1181
37. T.S. Mikkelsen, J. Hanna, X. Zhang, M. Ku, M. Wernig, P. Schorderet, B.E. Bernstein, R. Jaenisch, E.S. Lander, and A. Meissner Dissecting direct reprogramming through integrative genomic analysis Nature 454 2008 49 55
38. M. Nakagawa, M. Koyanagi, K. Tanabe, K. Takahashi, T. Ichisaka, T. Aoi, K. Okita, Y. Mochiduki, N. Takizawa, and S. Yamanaka Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts Nat. Biotechnol. 26 2008 101 106
39. B.N. Nicolay, and N.J. Dyson The multiple connections between pRB and cell metabolism Curr. Opin. Cell Biol. 25 2013 735 740
40. I.H. Park, R. Zhao, J.A. West, A. Yabuuchi, H. Huo, T.A. Ince, P.H. Lerou, M.W. Lensch, and G.Q. Daley Reprogramming of human somatic cells to pluripotency with defined factors Nature 451 2008 141 146
41. C. Qiu, Y. Ma, J. Wang, S. Peng, and Y. Huang Lin28-mediated post-transcriptional regulation of Oct4 expression in human embryonic stem cells Nucleic Acids Res. 38 2010 1240 1248
42. C.M. Rudin, S. Durinck, E.W. Stawiski, J.T. Poirier, Z. Modrusan, D.S. Shames, E.A. Bergbower, Y. Guan, J. Shin, and J. Guillory Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer Nat. Genet. 44 2012 1111 1116
43. J. Sage, G.J. Mulligan, L.D. Attardi, A. Miller, S. Chen, B. Williams, E. Theodorou, and T. Jacks Targeted disruption of the three Rb-related genes leads to loss of G(1) control and immortalization Genes Dev. 14 2000 3037 3050
44. A. Sarkar, and K. Hochedlinger The sox family of transcription factors: versatile regulators of stem and progenitor cell fate Cell Stem Cell 12 2013 15 30
45. S. Talluri, C.E. Isaac, M. Ahmad, S.A. Henley, S.M. Francis, A.L. Martens, R. Bremner, and F.A. Dick A G1 checkpoint mediated by the retinoblastoma protein that is dispensable in terminal differentiation but essential for senescence Mol. Cell. Biol. 30 2010 948 960
46. M. Tomioka, M. Nishimoto, S. Miyagi, T. Katayanagi, N. Fukui, H. Niwa, M. Muramatsu, and A. Okuda Identification of Sox-2 regulatory region which is under the control of Oct-3/4-Sox-2 complex Nucleic Acids Res. 30 2002 3202 3213
47. P. Viatour, and J. Sage Newly identified aspects of tumor suppression by RB Dis. Model. Mech. 4 2011 581 585
48. M. Wernig, A. Meissner, R. Foreman, T. Brambrink, M. Ku, K. Hochedlinger, B.E. Bernstein, and R. Jaenisch In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state Nature 448 2007 318 324
49. M. Wernig, A. Meissner, J.P. Cassady, and R. Jaenisch c-Myc is dispensable for direct reprogramming of mouse fibroblasts Cell Stem Cell 2 2008 10 12
50. X. Xu, M. Bieda, V.X. Jin, A. Rabinovich, M.J. Oberley, R. Green, and P.J. Farnham A comprehensive ChIP-chip analysis of E2F1, E2F4, and E2F6 in normal and tumor cells reveals interchangeable roles of E2F family members Genome Res. 17 2007 1550 1561